Tacrolimus, MMF, Steroid, and ALG Immunotherapy for High Immunological Risk Renal Transplant Recipients

Authors

J. Zaltzman, St Michael’s Hospital, Toronto, ON
Vivian McAlister, QEII Health Sciences Centre, Halifax, NS
D. Russell, St Joseph’s Hospital, Hamilton, ON
P. Halloran, University of Alberta
D. Landsberg, St Paul’s Hospital, Vancouver, BC
S. Busque, Hôpital Notre-Dame, Montréal, QC
A. Shoker, Royal University Hospital, Saskatoon, SK
A. Boucher, Hôpital Maisonneuve-Rosemont, Montréal, QC
J. Shapiro, Vancouver General Hospital, Vancouver, BC
J. Tchervenkov, Royal Victoria Hospital, Montreal, QC
J. Peets, Fujisawa Canada R&D, Markham, ON

Document Type

Article

Publication Date

2-2001

Journal

Transplantation Proceedings

Volume

33

Issue

1-2

First Page

1044

Last Page

1045

URL with Digital Object Identifier

http://dx.doi.org/10.1016/S0041-1345(00)02323-X

Notes

Dr. Vivian McAlister is currently a faculty member at The University of Western Ontario.